Teva Pharmaceutical Industries Limited
TEVJF
$29.19
$0.832.93%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -15.47% | 5.16% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.47% | 5.16% | |||
| Cost of Revenue | -2.19% | -5.51% | |||
| Gross Profit | -25.76% | 15.23% | |||
| SG&A Expenses | -10.71% | 15.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 17.65% | -288.89% | |||
| Total Operating Expenses | -6.04% | 0.35% | |||
| Operating Income | -40.62% | 20.54% | |||
| Income Before Tax | 384.44% | -86.11% | |||
| Income Tax Expenses | 117.18% | -282.24% | |||
| Earnings from Continuing Operations | -23.13% | 10.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | 100.00% | |||
| Net Income | -23.13% | 10.85% | |||
| EBIT | -40.62% | 20.54% | |||
| EBITDA | -35.15% | 17.49% | |||
| EPS Basic | -23.60% | 10.68% | |||
| Normalized Basic EPS | -49.43% | 29.22% | |||
| EPS Diluted | -24.13% | 10.43% | |||
| Normalized Diluted EPS | -49.37% | 28.46% | |||
| Average Basic Shares Outstanding | 0.61% | 0.17% | |||
| Average Diluted Shares Outstanding | 0.51% | 0.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||